{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:04:23Z","timestamp":1791014663560,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/maj.0b013e31820e7f05","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T07:50:53Z","timestamp":1304409053000},"page":"9-14","source":"Crossref","is-referenced-by-count":15,"title":["B Cell Activating Factor Gene Polymorphisms in Patients With Risk of Idiopathic Thrombocytopenic Purpura"],"prefix":"10.1016","volume":"342","author":[{"given":"Samah M.","family":"Abdel-Hamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend N.","family":"Al-Lithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0015","first-page":"229","article-title":"Thrombocytopenia, immune thrombocytopenia and idiopathic thrombocytopenic purpura","volume":"52","author":"Ozsoylu","year":"2010","journal-title":"Turk J Pediatr"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1634\/theoncologist.2008-0132","article-title":"Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis","volume":"14","author":"Gernsheimer","year":"2009","journal-title":"Oncologist"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0025","first-page":"356","article-title":"Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights","volume":"64","author":"Stevens","year":"2006","journal-title":"Netherlands J Med"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0030","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajh.20276","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura","volume":"78","author":"Braendstrup","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0040","first-page":"126","article-title":"Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study","volume":"52","author":"Yetgin","year":"2010","journal-title":"Turk J Pediatr"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0045","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1592\/phco.30.7.666","article-title":"Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on thrombopoietin agonists; romiplostim and eltrombopag","volume":"30","author":"Chouhan","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.coi.2005.04.005","article-title":"The role of APRIL and BAFF in lymphocyte activation","volume":"17","author":"Schneider","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1471-4906(01)02159-7","article-title":"The role of BAFF in B-cell maturation, T-cell activation and autoimmunity","volume":"23","author":"Mackay","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/08916930802397848","article-title":"BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura,","volume":"42","author":"Zhou","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mehy.2007.05.005","article-title":"BAFF - an essential survival factor for B cells: links to genesis of ITP and may be of therapeutic target","volume":"70","author":"Yu","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/0891693021000066333","article-title":"Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes","volume":"35","author":"Mackay","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.gene.6363923","article-title":"Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis","volume":"3","author":"Kawasaki","year":"2002","journal-title":"Genes Immunity"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0085","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2005.02.7938","article-title":"Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders","volume":"24","author":"Novak","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0090","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/rheumatology\/ken246","article-title":"Polymorphism in the 50 regulatory region of the B-lymphocyte activating factor gene is associated with the Ro\/La autoantibody response and serum BAFF levels in primary Sjogren\u2019s syndrome","volume":"47","author":"Nossent","year":"2008","journal-title":"Rheumatology"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0095","first-page":"305","article-title":"BAFF, APRIL and human B cell disorders","volume":"18","author":"Stuart","year":"2006","journal-title":"Immunology"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0100","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2002-10-3123","article-title":"Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF","volume":"101","author":"Craxton","year":"2003","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.coph.2004.02.009","article-title":"The role of the BAFF\/APRIL system in B cell homeostasis and lymphoid cancers","volume":"4","author":"Mackay","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2006.06431.x","article-title":"High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura","volume":"136","author":"Emmerich","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0115","first-page":"690","article-title":"Significance of B cell activating factor of TNF family promoter polymorphisms in patients with immune thrombocytopenic purpura","volume":"18","author":"Liu","year":"2010","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0120","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/0008-5472.CAN-08-4915","article-title":"Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma","volume":"69","author":"Novak","year":"2009","journal-title":"Cancer Res"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0125","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1884","article-title":"No evidence for an association between the -871 T\/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren\u2019s syndrome","volume":"8","author":"Gottenberg","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0130","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1182\/blood-2009-05-217513","article-title":"The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia","volume":"114","author":"Zhu","year":"2009","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1097\/MAJ.0b013e31820e7f05_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/ar1222","article-title":"The current status of targeting BAFF\/BLyS for autoimmune diseases","volume":"6","author":"Ramanujam","year":"2004","journal-title":"Arthritis Res Ther"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915312350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915312350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T20:19:58Z","timestamp":1592511598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915312350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0002962915312350"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e31820e7f05","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}